title: The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings.
abstract: Neuropsychiatric symptoms (NPS) of dementia include aggression, agitation, depression, anxiety, delusions, hallucinations, apathy, and disinhibition. NPS affect dementia patients nearly universally across dementia stages and etiologies. They are associated with poor patient and caregiver outcomes, including increased health care utilization, excess morbidity and mortality, and earlier nursing home placement, as well as caregiver stress, depression and reduced employment. There are no FDA-approved medications for NPS, but it is a common clinical practice to use psychotropic medications such as antipsychotics, to control symptoms; however, antipsychotics show only modest efficacy in improving NPS and have significant risks for patients, including side effects and mortality. Nonpharmacologic treatments are considered first-line by multiple medical bodies and expert consensus, as they show evidence for efficacy and have limited potential for adverse effects. Ideally, nonpharmacological management of NPS in clinical settings occurs in multidisciplinary teams, where occupational therapists play an important collaborative role in the care of the person with dementia. Our group has articulated an evidence-informed structured approach to the management of NPS that can be integrated into diverse practice settings and used by providers of various disciplines. The "DICE" (Describe, Investigate, Create, and Evaluate) approach is inherently patient- and caregiver-centered, as patient and caregiver concerns are integral to each step of the process. DICE offers a clinical reasoning approach through which providers can more efficiently and effectively choose optimal treatment plans. The purpose of this paper is to describe the role of the occupational therapy in using the DICE approach for NPS management.
authors.affiliation: 1Physical Medicine and Rehabilitation Services, VA Ann Arbor Healthcare System , Ann Arbor, Michigan , USA.
authors.forename: Joyce
authors.initials: J
authors.lastname: Fraker
authors.forename: Helen C
authors.initials: HC
authors.lastname: Kales
authors.forename: Mary
authors.initials: M
authors.lastname: Blazek
authors.forename: Janet
authors.initials: J
authors.lastname: Kavanagh
authors.forename: Laura N
authors.initials: LN
authors.lastname: Gitlin
mesh_terms: D000374:Aggression; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D057565:Apathy; D017028:Caregivers; D003299:Cooperative Behavior; D003702:Delusions / Q000209:etiology / Q000628:therapy; D003704:Dementia / Q000150:complications / Q000628:therapy*; D019468:Disease Management; D006212:Hallucinations / Q000209:etiology / Q000628:therapy; D006801:Humans; D001523:Mental Disorders / Q000209:etiology / Q000628:therapy; D009788:Occupational Therapy; D010348:Patient Care Team; D024382:Professional Role; D011595:Psychomotor Agitation / Q000209:etiology / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents